SCHEMBL5089461

SCHEMBL5089461

O=[C]OC(Cl)C(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2109211 0.73
SCHEMBL10384145 0.69
SCHEMBL1148828 0.67
SCHEMBL3380839 0.64
SCHEMBL17910251 0.63 MEN1 (0.33)
SCHEMBL3750985 0.63
SCHEMBL227419 0.63
SCHEMBL9894655 0.62
SCHEMBL11334423 0.60
SCHEMBL1148848 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432383-B2 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE-SERIPHARM (FR) 2008-10-07 US claimed
US-20070208185-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC 2007-09-06 US claimed
US-7220871-B2 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) 2007-05-22 US claimed
US-20050222089-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC 2005-10-06 US claimed
US-6825365-B2 FORMED AS ENANTIOMERS OF CIS-BETA-PHENYLGLYCIDIC ACID/BETA-PHENYLISOSERINE REACT WITH NITRILE COMPOUND VIA RITTER REACTION NOVASEP (FR) 2004-11-30 US claimed
US-20040220256-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC (FR) 2004-11-04 US claimed
US-20020068833-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM 2002-06-06 US claimed
EP-0863887-B1 INTERMEDIARY COMPOUNDS FOR THE HEMISYNTHESIS OF TAXANES AND PREPARATION PROCESSES THEREFOR SERIPHARM (FR) 2002-01-23 EP claimed
EP-0863887-A1 INTERMEDIARY COMPOUNDS FOR THE HEMISYNTHESIS OF TAXANES AND PREPARATION PROCESSES THEREFOR Societé d'Etude et de Recherche en Ingenierie Pharmaceutique Seripharm (FR) 1998-09-16 EP claimed
WO-1997015562-A1 INTERMEDIARY COMPOUNDS FOR THE HEMISYNTHESIS OF TAXANES AND PREPARATION PROCESSES THEREFOR SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) 1997-05-01 WO claimed
US-7432383-B2 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE-SERIPHARM (FR) 2008-10-07 US disclosed
US-7279586-B2 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) 2007-10-09 US disclosed
US-20070208185-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC 2007-09-06 US disclosed
US-7220871-B2 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) 2007-05-22 US disclosed
US-20050222089-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC 2005-10-06 US disclosed
US-6825365-B2 FORMED AS ENANTIOMERS OF CIS-BETA-PHENYLGLYCIDIC ACID/BETA-PHENYLISOSERINE REACT WITH NITRILE COMPOUND VIA RITTER REACTION NOVASEP (FR) 2004-11-30 US disclosed
US-20040220256-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor CHANTELOUP LUC (FR) 2004-11-04 US disclosed
US-20020068833-A1 Intermediates for the hemisynthesis of taxanes and preparation processes therefor SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM 2002-06-06 US disclosed
EP-0863887-B1 INTERMEDIARY COMPOUNDS FOR THE HEMISYNTHESIS OF TAXANES AND PREPARATION PROCESSES THEREFOR SERIPHARM (FR) 2002-01-23 EP disclosed
US-6265587-B1 REACTING ARYLGLYCIDATE WITH A NITRILE TO OBTAIN B-ARYLISOSERINE DERIVATIVE AND TREATING PRODUCT WITH LEWIS ACID TO OBTAIN OXAZOLINE COMPOUND SOCIETE D'ETUDE ET DE RECHERCHE EN INGENIERIE PHARMACEUTIQUE SERIPHARM (FR) 2001-07-24 US disclosed